Search Videos and More
News
International Consensus on the Evaluation and Management of : Results From a Modified Delphi Survey
Hypothalamic hamartomas (HH) are rare developmental brain lesions frequently associated with medically refractory epilepsy and complex neurobehavioral, cognitive and endocrine comorbidities.
News
De Novo Variants in the Splicing Factor Gene SF3B1 Are Associated with Neurodevelopmental Disorders
Constitutional variants in the splicing factor SF3B1 have been linked to neurodevelopmental disorders for the first time, according to a new multinational study co-authored by Phoenix Children’s Pediatric Neurologist and Neurogeneticist Michael Kruer, MD, et al.
News
American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy
This American Epilepsy Society (AES) practice guideline provides updated, evidence-based recommendations for the management of epilepsy in infants and children aged 1 month to <36 months.
News
Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome
The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.
News
IPSO 2026 Congress Case Presentation – Dr. Victoria Lorah
At the IPSO 2026 Congress in Paris, France, Victoria Lorah, DO, Child Neurology Co-Chief Resident at Phoenix Children's, presented a complex pediatric stroke case involving a two-year-old with an acute right middle cerebral artery (MCA) ischemic stroke.
News
The Digital Migraine Revolution: How Headache Tracking and Digital Health Are Changing Pediatric Care
Pediatric migraine has historically been managed in fragments – symptoms recalled across months of episodic appointments. At Phoenix Children's, digital tools are reshaping care from episodic to continuous.
News
Digital Health in Pediatric Neurology: From Episodic to Continuous Care
Digital health has emerged as a transformative force in 21st-century medicine, reshaping the boundaries of healthcare delivery.
News
Innovative, Minimally Invasive Treatment for Drug-Resistant Epilepsy
Epilepsy remains a life-altering condition, particularly due to the unpredictable nature of seizures and their cumulative impact on cognition, independence and quality of life.
News
2026 Children's Neuroscience Symposium
The 28th Annual Children's Neuroscience Symposium was held on Friday, April 10, 2026, at the Phoenix Children's Conference Center in Phoenix, Arizona.
News
Dannah Raz, MD, MPH, Named to Modern Healthcare’s 40 Under 40
Phoenix Children’s, one of the top-ranked pediatric health systems in the West, announced that Dannah Raz, MD, MPH, division chief of developmental and behavioral pediatrics, has been named to Modern Healthcare’s 40 Under 40 for 2026
News
IPSO Hemorrhagic Stroke Guidelines
The International Pediatric Stroke Organization (IPSO) Hemorrhagic Stroke Guidelines have now been published, featuring contributions from Janette Mailo, MD, of Phoenix Children’s Hospital.
News
A transposase-derived gene required for human brain development
A groundbreaking study published in Science Advances and featuring Phoenix Children’s investigators Michael Kruer, MD and Patricia Cornejo,, MD reveals a previously unknown requirement for somatic genetic diversity among neurons in normal brain development.